Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Johnson & Johnson CEO celebrates company’s cardiovascular business during Q4 earnings call
Johnson & Johnson reported $24.6 billion in sales for the fourth quarter of 2025, up 9.1% from the previous year. On an earnings call with investors, the company's CEO sang the praises of the company's cardiovascular health division.
AI agent calling cath lab patients to help them prepare for treatment
Mount Sinai Hospital in New York is now using AI-powered virtual agents to call some patients before cath lab procedures. The move was designed to help nurses focus more on patient care and reduce their risk of burnout.
Abbott works with AtaCor Medical on extravascular ICD system
Extravascular ICDs were developed to avoid complications such as vascular injuries, lead fractures and lead infections. Although rare, these issues can cause serious, life-threatening complications for patients.
Abbott secures key approval for new catheter capable of PFA, radiofrequency ablation
The TactiFlex Duo Ablation Catheter, Sensor Enabled was designed to switch from PFA to radiofrequency ablation as needed, providing electrophysiologists with options when treating AFib patients.
Post-TAVR echocardiography helps predict a patient’s long-term risk of SVD
Postprocedural gradients can tell cardiologists a lot about a patient's long-term risk of structural valve deterioration.

startup business healthcare medtech heart

Johnson & Johnson CEO celebrates company’s cardiovascular business during Q4 earnings call

Johnson & Johnson reported $24.6 billion in sales for the fourth quarter of 2025, up 9.1% from the previous year. On an earnings call with investors, the company's CEO sang the praises of the company's cardiovascular health division.

Andriy Vengrenyuk, MS, senior data analyst for interventional cardiology at the Icahn School of Medicine at Mount Sinai, explains a pilot program where artificial intelligence (AI) virtual agents call patients prior to their cath lab procedures to save nursing staff time doing administrative tasks.

AI agent calling cath lab patients to help them prepare for treatment

Mount Sinai Hospital in New York is now using AI-powered virtual agents to call some patients before cath lab procedures. The move was designed to help nurses focus more on patient care and reduce their risk of burnout.

Abbott recently announced it is partnering with AtaCor Medical to develop a next-generation extravascular implantable cardioverter defibrillator (EV-ICD) system. AtaCor's investigational extravascular ICD lead will be paired with Abbott's investigational extravascular ICD system.

Abbott works with AtaCor Medical on extravascular ICD system

Extravascular ICDs were developed to avoid complications such as vascular injuries, lead fractures and lead infections. Although rare, these issues can cause serious, life-threatening complications for patients.

Abbott secures key approval for new catheter capable of PFA, radiofrequency ablation

The TactiFlex Duo Ablation Catheter, Sensor Enabled was designed to switch from PFA to radiofrequency ablation as needed, providing electrophysiologists with options when treating AFib patients.

heart data research doctor cardiologist AI

Post-TAVR echocardiography helps predict a patient’s long-term risk of SVD

Postprocedural gradients can tell cardiologists a lot about a patient's long-term risk of structural valve deterioration.

Sunil Rao, MD, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, discusses the heart team approach in the context to determining what is best for the patient in terms of bypass surgery or percutaneous coronary intervention.

Heart teams playing a major role in coronary revascularization decisions

Sunil Rao, MD, discusses the heart team approach in the context of deciding what is best for the patient between bypass surgery and percutaneous coronary intervention.

The U.S. Food and Drug Administration (FDA) has cleared HeartLung Corporation's AI-CVD, an artificial intelligence (AI) algorithm that looks at 11 different opportunistic health screening assessments on chest CT exams ordered for any reason.

FDA clears opportunistic AI for detecting cardiothoracic issues in CT scans

“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.

Hospital patient bays recovery Banner Health and Atlas Ambulatory Surgical Center (ASC) in Sun City, Arizona.

Office-based interventional labs see boost in pay in 2026

CMS has made it a priority to increase payments for procedures performed by office-based labs and ambulatory surgical centers. This was reflected in policy changes made as part of the 2026 Medicare Physicians Fee Schedule.